Regulus Capex To Revenue from 2010 to 2024

RGLS Stock  USD 1.64  0.07  4.46%   
Regulus Therapeutics Capex To Revenue yearly trend continues to be comparatively stable with very little volatility. Capex To Revenue will likely drop to 0.0009 in 2024. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.000989
Current Value
0.00094
Quarterly Volatility
1.12961972
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regulus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regulus Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 215.7 K, Interest Expense of 1.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 4.03, Dividend Yield of 0.0 or PTB Ratio of 1.75. Regulus financial statements analysis is a perfect complement when working with Regulus Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Regulus Therapeutics Correlation against competitors.
For more information on how to buy Regulus Stock please use our How to Invest in Regulus Therapeutics guide.

Latest Regulus Therapeutics' Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Regulus Therapeutics over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Regulus Therapeutics' Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regulus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Very volatile
   Capex To Revenue   
       Timeline  

Regulus Capex To Revenue Regression Statistics

Arithmetic Mean0.42
Geometric Mean0.03
Coefficient Of Variation269.30
Mean Deviation0.59
Median0.04
Standard Deviation1.13
Sample Variance1.28
Range4.4296
R-Value(0.06)
Mean Square Error1.37
R-Squared0
Significance0.84
Slope(0.01)
Total Sum of Squares17.86

Regulus Capex To Revenue History

2024 9.4E-4
2023 9.89E-4
2020 0.001099
2019 0.0357
2018 0.31
2017 4.43
2016 0.81

About Regulus Therapeutics Financial Statements

Regulus Therapeutics shareholders use historical fundamental indicators, such as Capex To Revenue, to determine how well the company is positioned to perform in the future. Although Regulus Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Regulus Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Regulus Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Regulus Stock Analysis

When running Regulus Therapeutics' price analysis, check to measure Regulus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regulus Therapeutics is operating at the current time. Most of Regulus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Regulus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regulus Therapeutics' price. Additionally, you may evaluate how the addition of Regulus Therapeutics to your portfolios can decrease your overall portfolio volatility.